Lypro Biosciences is a therapeutic development company whose proprietary drug delivery nanotechnology increases the solubility and bioavailability of hydrophobic drugs and other therapeutic compounds and facilitates targeting to specific receptor(s). We have looked to the body's natural mechanisms for transporting insoluble compounds to develop our novel delivery platform. Lypro's technology is based on self-assembling, targetable, nanometer-scale bioparticles termed "NanoDisk". Incorporating hydrophobic bioactive agents into the stable and water-soluble NanoDisk holds the promise of increased efficacy, lower doses, and reduced incidence and severity of side effects compared to current formulations.
| Website | http://www.lyprobio.com |
| Revenue | $191000 |
| Employees | 1 (0 on RocketReach) |
| Founded | 2004 |
| Address | 953 Indiana St, San Francisco, California 94107, US |
| Phone | +1 510-748-9500 |
| Technologies |
JavaScript
,
HTML
,
ASP.NET
+5 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Biopharma, Business Services, Drug Delivery, Health Care, Science and Engineering, Pharmaceutical |
| Competitors | Geno, Synthace, Targeted Genetics, Zymergen, Inc., ADM, AstraZeneca, Corteva Agriscience, BASF, DuPont, Novozymes +37 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies |
Looking for a particular Lypro Biosciences employee's phone or email?
Lypro Biosciences Questions
The Lypro Biosciences annual revenue was $191000 in 2026.
Lypro Biosciences is based in San Francisco, California.
The NAICS codes for Lypro Biosciences are [541, 54171, 54, 5417, 541714].
The SIC codes for Lypro Biosciences are [87, 873].
Related Companies
